Chronic Idiopathic Constipation Drugs Market Report

Global and Region Chronic Idiopathic Constipation Drugs Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 31, 2022
  • PAGES：139
  • REPORT CODE：GMM937364
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Chronic Idiopathic Constipation Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Chronic Idiopathic Constipation Drugsmarket, defines the market attractiveness level of Chronic Idiopathic Constipation Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Chronic Idiopathic Constipation Drugs industry, describes the types of Chronic Idiopathic Constipation Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Chronic Idiopathic Constipation Drugs market and the development prospects and opportunities of Chronic Idiopathic Constipation Drugs industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Chronic Idiopathic Constipation Drugs market in Chapter 13.

    By Player:

    • Valeant Pharmaceuticals International

    • Eli Lilly

    • Glaxosmithkline

    • Theravance Biopharma Inc

    • Ironwood Pharmaceuticals Inc

    • Daiichi Sankyo

    • Progenics Pharmaceuticals Inc

    • Bayer AG

    • Sucampo Pharmaceuticals Inc

    • Chugai Pharmaceutical

    • Salix Pharmaceuticals Ltd

    • Pfizer

    • Ferring International Center SA

    • Merck

    • Cosmo Pharmaceuticals SA

    • Sanofi

    • Allergens

    • Roche Holding AG

    • Synergy Pharmaceuticals

    By Type:

    • Linaclotide

    • Lubiprostone

    • Other

    By End-User:

    • Hospital Pharmacies

    • Retail Pharmacies

    • Online Pharmacies

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Chronic Idiopathic Constipation Drugs Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Chronic Idiopathic Constipation Drugs Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Chronic Idiopathic Constipation Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Chronic Idiopathic Constipation Drugs Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Chronic Idiopathic Constipation Drugs Market Analysis and Outlook to 2022

    • 7.1 Global Chronic Idiopathic Constipation Drugs Consumption (2017-2022)

    • 7.2 United States Chronic Idiopathic Constipation Drugs Consumption (2017-2022)

    • 7.3 Europe Chronic Idiopathic Constipation Drugs Consumption (2017-2022)

    • 7.4 China Chronic Idiopathic Constipation Drugs Consumption (2017-2022)

    • 7.5 Japan Chronic Idiopathic Constipation Drugs Consumption (2017-2022)

    • 7.6 India Chronic Idiopathic Constipation Drugs Consumption (2017-2022)

    • 7.7 South Korea Chronic Idiopathic Constipation Drugs Consumption (2017-2022)

    8 Region and Country-wise Chronic Idiopathic Constipation Drugs Market Analysis and Outlook to 2028

    • 8.1 Global Chronic Idiopathic Constipation Drugs Consumption Forecast (2022-2028)

    • 8.2 United States Chronic Idiopathic Constipation Drugs Consumption Forecast (2022-2028)

    • 8.3 Europe Chronic Idiopathic Constipation Drugs Consumption Forecast (2022-2028)

    • 8.4 China Chronic Idiopathic Constipation Drugs Consumption Forecast (2022-2028)

    • 8.5 Japan Chronic Idiopathic Constipation Drugs Consumption Forecast (2022-2028)

    • 8.6 India Chronic Idiopathic Constipation Drugs Consumption Forecast (2022-2028)

    • 8.7 South Korea Chronic Idiopathic Constipation Drugs Consumption Forecast (2022-2028)

    9 Global Chronic Idiopathic Constipation Drugs Market Outlook by Types and Applications to 2022

    • 9.1 Global Chronic Idiopathic Constipation Drugs Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Linaclotide Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Lubiprostone Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Other Consumption and Growth Rate (2017-2022)

    • 9.2 Global Chronic Idiopathic Constipation Drugs Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Online Pharmacies Consumption and Growth Rate (2017-2022)

    10 Global Chronic Idiopathic Constipation Drugs Market Outlook by Types and Applications to 2028

    • 10.1 Global Chronic Idiopathic Constipation Drugs Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Linaclotide Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Lubiprostone Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Other Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Chronic Idiopathic Constipation Drugs Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    11 Global Chronic Idiopathic Constipation Drugs Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Chronic Idiopathic Constipation Drugs Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Chronic Idiopathic Constipation Drugs Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Chronic Idiopathic Constipation Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Chronic Idiopathic Constipation Drugs Market Competitive Analysis

    • 14.1 Valeant Pharmaceuticals International

      • 14.1.1 Valeant Pharmaceuticals International Company Details

      • 14.1.2 Valeant Pharmaceuticals International Chronic Idiopathic Constipation Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Valeant Pharmaceuticals International Chronic Idiopathic Constipation Drugs Product and Service

    • 14.2 Eli Lilly

      • 14.2.1 Eli Lilly Company Details

      • 14.2.2 Eli Lilly Chronic Idiopathic Constipation Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Eli Lilly Chronic Idiopathic Constipation Drugs Product and Service

    • 14.3 Glaxosmithkline

      • 14.3.1 Glaxosmithkline Company Details

      • 14.3.2 Glaxosmithkline Chronic Idiopathic Constipation Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Glaxosmithkline Chronic Idiopathic Constipation Drugs Product and Service

    • 14.4 Theravance Biopharma Inc

      • 14.4.1 Theravance Biopharma Inc Company Details

      • 14.4.2 Theravance Biopharma Inc Chronic Idiopathic Constipation Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Theravance Biopharma Inc Chronic Idiopathic Constipation Drugs Product and Service

    • 14.5 Ironwood Pharmaceuticals Inc

      • 14.5.1 Ironwood Pharmaceuticals Inc Company Details

      • 14.5.2 Ironwood Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Ironwood Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Product and Service

    • 14.6 Daiichi Sankyo

      • 14.6.1 Daiichi Sankyo Company Details

      • 14.6.2 Daiichi Sankyo Chronic Idiopathic Constipation Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Daiichi Sankyo Chronic Idiopathic Constipation Drugs Product and Service

    • 14.7 Progenics Pharmaceuticals Inc

      • 14.7.1 Progenics Pharmaceuticals Inc Company Details

      • 14.7.2 Progenics Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Progenics Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Product and Service

    • 14.8 Bayer AG

      • 14.8.1 Bayer AG Company Details

      • 14.8.2 Bayer AG Chronic Idiopathic Constipation Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Bayer AG Chronic Idiopathic Constipation Drugs Product and Service

    • 14.9 Sucampo Pharmaceuticals Inc

      • 14.9.1 Sucampo Pharmaceuticals Inc Company Details

      • 14.9.2 Sucampo Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Sucampo Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Product and Service

    • 14.10 Chugai Pharmaceutical

      • 14.10.1 Chugai Pharmaceutical Company Details

      • 14.10.2 Chugai Pharmaceutical Chronic Idiopathic Constipation Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Chugai Pharmaceutical Chronic Idiopathic Constipation Drugs Product and Service

    • 14.11 Salix Pharmaceuticals Ltd

      • 14.11.1 Salix Pharmaceuticals Ltd Company Details

      • 14.11.2 Salix Pharmaceuticals Ltd Chronic Idiopathic Constipation Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Salix Pharmaceuticals Ltd Chronic Idiopathic Constipation Drugs Product and Service

    • 14.12 Pfizer

      • 14.12.1 Pfizer Company Details

      • 14.12.2 Pfizer Chronic Idiopathic Constipation Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Pfizer Chronic Idiopathic Constipation Drugs Product and Service

    • 14.13 Ferring International Center SA

      • 14.13.1 Ferring International Center SA Company Details

      • 14.13.2 Ferring International Center SA Chronic Idiopathic Constipation Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Ferring International Center SA Chronic Idiopathic Constipation Drugs Product and Service

    • 14.14 Merck

      • 14.14.1 Merck Company Details

      • 14.14.2 Merck Chronic Idiopathic Constipation Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Merck Chronic Idiopathic Constipation Drugs Product and Service

    • 14.15 Cosmo Pharmaceuticals SA

      • 14.15.1 Cosmo Pharmaceuticals SA Company Details

      • 14.15.2 Cosmo Pharmaceuticals SA Chronic Idiopathic Constipation Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Cosmo Pharmaceuticals SA Chronic Idiopathic Constipation Drugs Product and Service

    • 14.16 Sanofi

      • 14.16.1 Sanofi Company Details

      • 14.16.2 Sanofi Chronic Idiopathic Constipation Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 Sanofi Chronic Idiopathic Constipation Drugs Product and Service

    • 14.17 Allergens

      • 14.17.1 Allergens Company Details

      • 14.17.2 Allergens Chronic Idiopathic Constipation Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 Allergens Chronic Idiopathic Constipation Drugs Product and Service

    • 14.18 Roche Holding AG

      • 14.18.1 Roche Holding AG Company Details

      • 14.18.2 Roche Holding AG Chronic Idiopathic Constipation Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.18.3 Roche Holding AG Chronic Idiopathic Constipation Drugs Product and Service

    • 14.19 Synergy Pharmaceuticals

      • 14.19.1 Synergy Pharmaceuticals Company Details

      • 14.19.2 Synergy Pharmaceuticals Chronic Idiopathic Constipation Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.19.3 Synergy Pharmaceuticals Chronic Idiopathic Constipation Drugs Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Chronic Idiopathic Constipation Drugs

    • Figure Chronic Idiopathic Constipation Drugs Picture

    • Table Global Chronic Idiopathic Constipation Drugs Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Chronic Idiopathic Constipation Drugs Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Chronic Idiopathic Constipation Drugs Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Chronic Idiopathic Constipation Drugs Consumption by Country (2017-2022)

    • Figure United States Chronic Idiopathic Constipation Drugs Consumption and Growth Rate (2017-2022)

    • Table Europe Chronic Idiopathic Constipation Drugs Consumption and Growth Rate (2017-2022)

    • Figure China Chronic Idiopathic Constipation Drugs Consumption and Growth Rate (2017-2022)

    • Figure Japan Chronic Idiopathic Constipation Drugs Consumption and Growth Rate (2017-2022)

    • Figure India Chronic Idiopathic Constipation Drugs Consumption and Growth Rate (2017-2022)

    • Figure South Korea Chronic Idiopathic Constipation Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Chronic Idiopathic Constipation Drugs Consumption Forecast by Country (2022-2028)

    • Figure United States Chronic Idiopathic Constipation Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Chronic Idiopathic Constipation Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Chronic Idiopathic Constipation Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Chronic Idiopathic Constipation Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Chronic Idiopathic Constipation Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Chronic Idiopathic Constipation Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Linaclotide Consumption and Growth Rate (2017-2022)

    • Figure Global Lubiprostone Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Online Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Linaclotide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Lubiprostone Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Chronic Idiopathic Constipation Drugs Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Chronic Idiopathic Constipation Drugs Export by Region (Top 5 Countries) (2017-2028)

    • Table Valeant Pharmaceuticals International (Foundation Year, Company Profile and etc.)

    • Table Valeant Pharmaceuticals International Chronic Idiopathic Constipation Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Valeant Pharmaceuticals International Chronic Idiopathic Constipation Drugs Product and Service

    • Table Eli Lilly (Foundation Year, Company Profile and etc.)

    • Table Eli Lilly Chronic Idiopathic Constipation Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly Chronic Idiopathic Constipation Drugs Product and Service

    • Table Glaxosmithkline (Foundation Year, Company Profile and etc.)

    • Table Glaxosmithkline Chronic Idiopathic Constipation Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Glaxosmithkline Chronic Idiopathic Constipation Drugs Product and Service

    • Table Theravance Biopharma Inc (Foundation Year, Company Profile and etc.)

    • Table Theravance Biopharma Inc Chronic Idiopathic Constipation Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Theravance Biopharma Inc Chronic Idiopathic Constipation Drugs Product and Service

    • Table Ironwood Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)

    • Table Ironwood Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ironwood Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Product and Service

    • Table Daiichi Sankyo (Foundation Year, Company Profile and etc.)

    • Table Daiichi Sankyo Chronic Idiopathic Constipation Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Daiichi Sankyo Chronic Idiopathic Constipation Drugs Product and Service

    • Table Progenics Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)

    • Table Progenics Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Progenics Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Product and Service

    • Table Bayer AG (Foundation Year, Company Profile and etc.)

    • Table Bayer AG Chronic Idiopathic Constipation Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer AG Chronic Idiopathic Constipation Drugs Product and Service

    • Table Sucampo Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)

    • Table Sucampo Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sucampo Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Product and Service

    • Table Chugai Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Chugai Pharmaceutical Chronic Idiopathic Constipation Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Chugai Pharmaceutical Chronic Idiopathic Constipation Drugs Product and Service

    • Table Salix Pharmaceuticals Ltd (Foundation Year, Company Profile and etc.)

    • Table Salix Pharmaceuticals Ltd Chronic Idiopathic Constipation Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Salix Pharmaceuticals Ltd Chronic Idiopathic Constipation Drugs Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Chronic Idiopathic Constipation Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Chronic Idiopathic Constipation Drugs Product and Service

    • Table Ferring International Center SA (Foundation Year, Company Profile and etc.)

    • Table Ferring International Center SA Chronic Idiopathic Constipation Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ferring International Center SA Chronic Idiopathic Constipation Drugs Product and Service

    • Table Merck (Foundation Year, Company Profile and etc.)

    • Table Merck Chronic Idiopathic Constipation Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Chronic Idiopathic Constipation Drugs Product and Service

    • Table Cosmo Pharmaceuticals SA (Foundation Year, Company Profile and etc.)

    • Table Cosmo Pharmaceuticals SA Chronic Idiopathic Constipation Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cosmo Pharmaceuticals SA Chronic Idiopathic Constipation Drugs Product and Service

    • Table Sanofi (Foundation Year, Company Profile and etc.)

    • Table Sanofi Chronic Idiopathic Constipation Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Chronic Idiopathic Constipation Drugs Product and Service

    • Table Allergens (Foundation Year, Company Profile and etc.)

    • Table Allergens Chronic Idiopathic Constipation Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Allergens Chronic Idiopathic Constipation Drugs Product and Service

    • Table Roche Holding AG (Foundation Year, Company Profile and etc.)

    • Table Roche Holding AG Chronic Idiopathic Constipation Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Holding AG Chronic Idiopathic Constipation Drugs Product and Service

    • Table Synergy Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Synergy Pharmaceuticals Chronic Idiopathic Constipation Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Synergy Pharmaceuticals Chronic Idiopathic Constipation Drugs Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US